gluten-free cereal products emphasise the technological uniqueness of the three Triticeae cereals: wheat, rye, and barley. The gluten-free cereal food business also involves regulatory issues, safety aspects, and nutritional questions, etc. This review briefly discusses some of the topics handled at the symposium.
The Triggering Protein
The symposium began with an overview of coeliac disease itself-its symptoms, autoimmune nature, and increasing prevalence, as presented by Markku Mäki, of Tampere, Finland, which was followed by Peter Köhler, Freising, Germany, who gave an update on gluten chemistry and also discussed what is meant by the term "gluten-free" (1) . In cereal science and technology, gluten refers to wheat gluten which gives wheat its well-known unique properties. However, in the context of coeliac disease, gluten includes all storage proteins of wheat, rye, and barley that can be isolated by alcohol extraction after reduction, i.e., prolamins. These proteins are characterised by a high content of glutamine and proline, and they contain structures that are digested relatively slowly by the human digestive system. In persons intolerant to gluten, something in their protein structure causes an inflammation of the small intestine epithelium. In order to avoid damage to the villus of the intestine, coeliac patients have to strictly avoid gluten for the rest of their lives, which is the only treatment available. The smallest peptides known to be harmful contain nine amino acids in a certain sequence with QQQP representing one of the key sequences (Q = glutamine, and P = proline).
Elimination by Plant Breeding?
A plant breeder's approach would be to eliminate the harmful proteins or sequences by using selected breeding lines and molecular techniques. However, the harmful sequences are very common in the proteins of the Triticeae cereals (i.e., wheat, rye, 
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• Proteins triggering celiac disease; effects, properties, chemistry, and analysis • Potential elimination of gluten toxicity by plant breeding or processing • Safety assurance of gluten-free foods • Thresholds for gluten-free foods and regulatory issues • Gluten-free food market • Nutritional quality of gluten-free foods • Pseudocereals in gluten-free foods • Wheat starch and oats in gluten-free foods • Gluten-free baking and gluten replacement • Gluten-free pasta and beer and barley). Luud Gilissen, Wageningen, the Netherlands, suggested that the "toxicity" of wheat might have increased with continued breeding for improved baking properties, but at least some gluten proteins, such as the alpha-gliadins, which have a high frequency of toxic sequences, could be removed without affecting baking quality (1) . Thousands of wheat breeding lines have now been collected in order to be checked from the coeliac point of view.
Elimination by Enzymes?
Great expectations arose a few years ago when it was suggested that specific proteolytic enzymes (i.e., proline endopeptidases [POP or PEP enzymes]) could be used to break down gluten and make it harmless in the stomach, allowing the coeliac patient to tolerate gluten provided an PEP enzyme pill is taken with food. This strategy would be analogous to lactase-degrading pills taken by those with lactose intolerance. However, the quantitative degradation of gluten is challenging in stomach conditions. Pharmacological use of the PEP enzymes would possibly first apply to the removal of potential gluten residues, rather than allow the coeliac patient to eat normal gluten-containing foods. Frits Koning, Leiden, the Netherlands, acquainted the audience with a particular Aspergillus niger proline endopeptidase (AN-PEP), which is currently being clinically tested (1). Endogenous peptidases of cereal origin, such as those present in malted cereals, can also be used for prolamin degradation in certain food applications, such as in brewing. Jussi Loponen, Helsinki, Finland, introduced a sourdough baking process involving rye malt, which was shown to be particularly efficient in prolamin degradation (1). With less than 0.5% prolamin left in such rye sourdough, it could be used as a flavouring ingredient in otherwise gluten-free baking.
Inactivation of Gluten "Toxicity"
Transamidating enzymes could be possibly used to modify gluten and reduce its immunotoxicity. This was discussed by Mauro Rossi, Avellino, Italy, whose results indicated that detection of gluten was blocked by the treatment (1). Another new approach for gluten blocking was presented by Karolina Hoffmann, Gothenburg, Sweden, whose in vitro studies suggested that synthetic blocking peptides could be used to reduce gliadin immunotoxicity (1).
New Regulatory Limits for Gluten Free
The new threshold for gluten free is now 20 mg/kg (E.U. Commission Regulation No 41/2009), which is 10 times lower than the earlier limit (200 mg/kg) (1). The new rule has been of some concern especially in Nordic countries where wheat starch has been traditionally used by gluten-free food manufacturers and coeliac patients. Wheat starch, fulfilling the new strict limit, is now available, although at a higher price. The new regulation also affected the position of oats, and apparently led to a reduced variety of products in the market, at least for a while. These aspects were brought up in some papers discussing residual gluten, assortment available, and compliance to the gluten-free diet. Certainly, the GF 10 Symposium was an excellent forum for such discussions.
Gluten-Free Analysis
Gluten-free analysis has been based on immunological ELISA methods for more than 20 years, and this also applies to the current Codex-endorsed R5 ELISA procedure (acc to Mendez), which recognises pentapeptides within the prolamin sequence. Sigrid Haas-Lauterbach, R-Biopharm, Germany, introduced a new version of competitive-ELISA, a variant of the technique, allowing comparable results with the regular R5 method and improved detection of hydrolyzed proteins (e.g., in beer).
New ELISA methods based on antibodies raised against other peptides were also introduced, and possibly-after a Codex validation step-alternative or complementary methods will be available for the quantification of residual gluten.
Other Cereals, Pseudocereals, and Gluten Replacers
Internationally, most of the gluten-free breads and pastas are based on corn or rice starches. In Nordic countries, wheat starch has also been widely used because it is considered to be technologically better and improves product quality. Pseudocereals, such as buckwheat, amaranth, and quinoa, are also available, and their use in gluten-free products was reported in many papers dealing with technology and product development. It is obvious that there is a need for a universal gluten replacer. Such a product would have great market potential. Bill Atwell, Cargill, U.S.A., suggested an ingredient consisting of tapioca starch and xanthan gum to solve problems in gluten-free cookie, cake, and bread baking.
Vienna 2013
The 3rd International Symposium on Gluten-Free Cereal Products will be held in 2013 in Vienna. In three years' time there will be some experience on how the new E.U. regulation has affected gluten-free cereal food business, the availability of products, and the health and quality of life of those intolerant to gluten. New technological solutions will be seen and new analytical methods will be available.
